Intercalating of AIEgens into MoS 2 nanosheets to induce crystal phase transform for enhanced photothermal and photodynamic synergetic anti-tumor therapy

Jiaxin Li,Yanzhi Xing,Xuwei Chen
DOI: https://doi.org/10.1016/j.talanta.2024.125677
IF: 6.1
2024-01-21
Talanta
Abstract:A MoS 2 -based nanotherapeutic platform was developed for synergetic photothermal and photodynamic anti-tumor therapy. AIEgens TFPy-SH molecules were intercalated into MoS 2 nanosheets (MoS 2 NSs) with S-deficiencies to give the nanocomposite MoS 2 -TFPy. The AIEgens intercalation expanded the interlayer spacing of MoS 2 NSs and induced the transform of MoS 2 crystal phase from 2H to 1T, offering MoS 2 -TFPy nanocomposite high molar absorption coefficient (5.65 L g −1 cm −1 ), excellent photothermal conversion efficiency under near-infrared (NIR) laser irradiation (38.3%), and favorable intracellular reactive oxygen species (ROS) generation capacity. The positively charged MoS 2 -TFPy were mainly distributed in mitochondria after cell up-taking, and achieved 1+1>2 anti-tumor effect attributed to its favorable photothermal and photodynamic properties. The high structure and physiological stability, favorable biocompatibility, excellent photothermal and photodynamic therapy effect make the MoS 2 -TFPy nanoplatform an promising candidate in biomedical clinical applications.
chemistry, analytical
What problem does this paper attempt to address?